Streptomyces sioyaensis Lv81 produces siomycin, a thiopeptide antibiotic synthesized on ribosomes. Nothing is known about the ability of this strain to produce nonribosomal peptides, a well represented group of natural actinomycete compounds. Using degenerate primers, we cloned a number of DNA fragments encoding putative adenylation domains (A domains) of nonribisomal peptide synthetases involved in biosynthesis of unknown compounds. Sequencing of amplicons revealed nine different A domains, which were analyzed in more detail. Nonribosomal codes of these domains were determined, but in most cases their substrate specificity failed to be unambiguously predicted. This means that many of these domains can recognize novel amino acids and be used to improve and expand the bioinformatic toolbox applied to predict substrate specificity of A domains. Multiple sequence alingments showed that the cloned A domains are probably involved in different biosynthetic pathways. Five A domains were used in gene inactivation experiments. Inactivation of one of them (in strain 736) resulted in a decrease of the total antibiotic activity as compared to the initial strain. Other A-domain mutants were similar to the initial strain in morphology and siomycin production. The causes of reduced antibiotic activity of strain 736 are discussed.
Russian Journal of Genetics – Springer Journals
Published: Jul 22, 2010
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera